{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:01:15Z","timestamp":1772218875644,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polyradiculoneuropathy following infection with varicella zoster virus (VZV) is rare and most of the time, happens in the context of reactivation of latent VZV. We report a case of acute polyradiculoneuropathy following primary infection with VZV marked by atypical clinical features raising the hypothesis of a para-infectious disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe a 43-years-old male who developed ataxia, dysphagia, dysphonia, and oculomotor disorders (vertical binocular diplopia and bilateral ptosis) followed by quadriplegia with areflexia which occurred 4\u00a0days later. The patient had a history of varicella that occurred 10\u00a0days before the onset of these symptoms. Nerve conduction study revealed features consistent with an acute motor-sensory axonal neuropathy (AMSAN). Anti-ganglioside antibodies were negative.<\/jats:p>\n                <jats:p>Based on clinical presentation and ancillary examination, we retain the Miller Fisher\/Guillain-Barr\u00e9 overlap syndrome diagnosis.<\/jats:p>\n                <jats:p>The patient was treated with high doses of methylprednisolone but the evolution of the disease was nevertheless marked by a complete recovery six weeks after onset of symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>GBS following varicella is a rare but severe disease occurring most often in adults and marked by greater involvement of the cranial nerves. Its clinical features suggest that it is a para-infectious disease. Antiviral therapy has no effect on the course of the disease but its administration within the first 24\u00a0h after the onset of chickenpox in adults can prevent its occurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03185-8","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:03:26Z","timestamp":1680159806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is Guillain\u2013Barre syndrome following chickenpox a parainfectious disease? A case report and literature review"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-6813","authenticated-orcid":false,"given":"Bademain Jean Fabrice","family":"Ido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidi Mahamoud","family":"Guebre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline Agathe","family":"Carama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred Anselme","family":"Dabilgou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Napon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"3185_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/tmi.13181","volume":"24","author":"VK Wachira","year":"2019","unstructured":"Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007\u20132017: What has changed? Trop Med Int Health. 2019;24:132\u201342.","journal-title":"Trop Med Int Health"},{"key":"3185_CR2","first-page":"96","volume":"16","author":"S Esposito","year":"2017","unstructured":"Esposito S, Longo MR. Guillain-Barr\u00e9 syndrome Autoimmune Rev. 2017;16:96\u2013101.","journal-title":"Guillain-Barr\u00e9 syndrome Autoimmune Rev"},{"key":"3185_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10096-018-3199-5","volume":"37","author":"B Islam","year":"2018","unstructured":"Islam B, Islam Z, Geurtsvankessel CH, Jahan I, Endtz HP, Mohammad QD, et al. Guillain-Barr\u00e9 syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. 2018;37:511\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3185_CR4","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.ijid.2009.03.019","volume":"14","author":"F Cresswell","year":"2010","unstructured":"Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain-Barr\u00e9 syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis. 2010;14(2):e161\u20133.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3185_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18282\/rcsm.v1.i1.12","volume":"1","author":"LD Lompo","year":"2018","unstructured":"Lompo LD, Maitrot A, Aubertin A, Khatib M, Decombes R, Billaud B. Miller Fisher syndrome on the borders of Guillain-Barre syndrome: about one case and review of literature. Clin Med Rep. 2018;1(1):1\u20135.","journal-title":"Clin Med Rep"},{"issue":"5","key":"3185_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/mus.20835","volume":"36","author":"YL Lo","year":"2007","unstructured":"Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007;36(5):615\u201327.","journal-title":"Muscle Nerve"},{"key":"3185_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1086\/655136","volume":"51","author":"JH Kang","year":"2010","unstructured":"Kang JH, Sheu JJ, Lin HC. Increased Risk of Guillain-Barr\u00e9 syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis. 2010;51:525\u201330.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3185_CR8","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1080\/21645515.2021.1985890","volume":"17","author":"TC Anderson","year":"2021","unstructured":"Anderson TC, Leung JW, Harpaz R, Dooling KL. Risk of Guillain-Barr\u00e9 syndrome following herpes zoster, United States, 2010\u20132018. Hum Vaccin Immunother. 2021;17(12):5304\u201310.","journal-title":"Hum Vaccin Immunother"},{"issue":"sp\u00e9cial","key":"3185_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0399-077X(98)80103-0","volume":"28","author":"AM Fillet","year":"1998","unstructured":"Fillet AM. Histoire naturelle de l\u2019infection \u00e0 VZV\u00a0: physiopathologie, m\u00e9canisme d\u2019action et crit\u00e8res virologiques d\u2019\u00e9valuation des antiviraux. M\u00e9d Mal Infect. 1998;28(sp\u00e9cial):767\u201374.","journal-title":"M\u00e9d Mal Infect"},{"issue":"16","key":"3185_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1212\/WNL.0b013e3181bd13b3","volume":"73","author":"A Cortese","year":"2009","unstructured":"Cortese A, Tavazzi E, Delbue S, Alfonsi E, Pichiecchio A, Ceroni M, Ferrante P, Marchioni E. Varicella zoster virus-associated polyradiculoneuritis. Neurology. 2009;73(16):1334\u20135.","journal-title":"Neurology"},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"S Najjar","year":"2020","unstructured":"Najjar S, Najjar A, Chong DJ, Pramanik DK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.","journal-title":"J Neuroinflammation"},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/00207454.2015.1033621","volume":"126","author":"P Tatarelli","year":"2016","unstructured":"Tatarelli P, Garnero M, Del Bono V, Camera M, Schenone A, Grandis M, Benedetti L, Viscoli C. Guillain-Barr\u00e9 syndrome following chickenpox: a case series. Int J Neurosci. 2016;126:478\u20139.","journal-title":"Int J Neurosci"},{"key":"3185_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/1744666X.2016.1193006","volume":"12","author":"AK Jasti","year":"2016","unstructured":"Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12:1175\u201389.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"3185_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of the tropism of varicella-zoster virus pathogenesis. Nat Rev Microbiol. 2014;12(3):197\u2013210.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"3185_CR15","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/JVI.03375-14","volume":"90","author":"N Sen","year":"2016","unstructured":"Sen N, Arvin AM. Dissecting the molecular mechanisms of the tropism of varicella-zoster virus for human T cells. J Virol. 2016;90(7):3284\u20137.","journal-title":"J Virol"},{"key":"3185_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1600-0714.2009.00802.x","volume":"38","author":"MB Mustafa","year":"2009","unstructured":"Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med. 2009;38:673\u201388.","journal-title":"J Oral Pathol Med"},{"key":"3185_CR17","first-page":"586","volume":"341","author":"Guillain-Barr\u00e9 syndrome steroid trial group","year":"1993","unstructured":"Guillain-Barr\u00e9 syndrome steroid trial group. Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome. Lancet. 1993;341:586\u201390.","journal-title":"Lancet"},{"key":"3185_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RAC Hugues","year":"1978","unstructured":"Hugues RAC, Newsom-David JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750\u20133.","journal-title":"Lancet"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11940-010-0103-8","volume":"13","author":"M Mori","year":"2011","unstructured":"Mori M, Kuwabara S. Fisher syndrome. Curr Treat Options Neurol. 2011;13:71\u20138.","journal-title":"Curr Treat Options Neurol"},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","volume":"56","author":"M Mori","year":"2001","unstructured":"Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104\u20136.","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03185-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T07:04:50Z","timestamp":1680159890000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03185-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03185-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Bogodogo University Hospital. The authors acquired the patient\u2019s consent for the involvement in and publishing of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors acquired the patient\u2019s written consent for the involvement in and publishing of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}